Gastrointestinal tract cancers: Genetics, heritability and germ line mutations (Review)
- Authors:
- Xiao-Peng Lv
-
Affiliations: Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical College, The Affiliated Xuzhou Hospital of Medical College of Southeast University, Xuzhou, Jiangsu 221009, P.R. China - Published online on: January 20, 2017 https://doi.org/10.3892/ol.2017.5629
- Pages: 1499-1508
-
Copyright: © Lv . This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Grady WM and Markowitz SD: Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet. 3:101–128. 2002. View Article : Google Scholar : PubMed/NCBI | |
Garber JE and Offit K: Hereditary cancer predisposition syndromes. J Clin Oncol. 23:276–292. 2005. View Article : Google Scholar : PubMed/NCBI | |
Jasperson KW, Tuohy TM, Neklason DW and Burt RW: Hereditary and familial colon cancer. Gastroenterology. 138:2044–2058. 2010. View Article : Google Scholar : PubMed/NCBI | |
Oliveira C, Seruca R and Carneiro F: Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol. 14:21–33. 2006. View Article : Google Scholar : PubMed/NCBI | |
Entius MM, Keller JJ, Westerman AM, van Rees BP, van Velthuysen ML, de Goeij AF, Wilson JH, Giardiello FM and Offerhaus GJ: Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome. J Clin Pathol. 54:126–131. 2001. View Article : Google Scholar : PubMed/NCBI | |
Torrezan GT, da Silva FC, Santos EM, Krepischi AC, Achatz MI, Aguiar S Jr, Rossi BM and Carraro DM: Mutational spectrum of the APC and MUTYH genes and genotype-phenotype correlations in Brazilian FAP, AFAP, and MAP patients. Orphanet J Rare Dis. 8:542013. View Article : Google Scholar : PubMed/NCBI | |
Attard TM, Abraham SC and Cuffari C: The clinical spectrum of duodenal polyps in pediatrics. J Pediatr Gastroenterol Nutr. 36:116–119. 2003. View Article : Google Scholar : PubMed/NCBI | |
Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomäki P, Mecklin JP and Järvinen HJ: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 81:214–218. 1999. View Article : Google Scholar : PubMed/NCBI | |
Rowley PT: Inherited susceptibility to colorectal cancer. Annu Rev Med. 56:539–554. 2005. View Article : Google Scholar : PubMed/NCBI | |
Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S and Gruber SB: Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 137:1621–1627. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF and Boland CR: Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 76:1–18. 2009. View Article : Google Scholar : PubMed/NCBI | |
Douglas JA, Gruber SB, Meister KA, Bonner J, Watson P, Krush AJ and Lynch HT: History and molecular genetics of Lynch syndrome in family G: a century later. JAMA. 294:2195–2202. 2005. View Article : Google Scholar : PubMed/NCBI | |
Lynch HT and de la Chapelle A: Hereditary colorectal cancer. N Engl J Med. 348:919–932. 2003. View Article : Google Scholar : PubMed/NCBI | |
Lynch HT and Lynch J: Lynch syndrome: genetics, natural history, genetic counseling, and prevention. J Clin Oncol. 18:(Suppl 21). 19S–31S. 2000.PubMed/NCBI | |
Gruber SB: New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing. Gastroenterology. 130:577–587. 2006. View Article : Google Scholar : PubMed/NCBI | |
Lu KH and Broaddus RR: Gynecologic cancers in lynch syndrome/hnpcc. Fam Cancer. 4:249–254. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, La Jeunesse J, Nakagawa H, Westman JA, et al: Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 66:7810–7817. 2006. View Article : Google Scholar : PubMed/NCBI | |
Eng C, Hampel H and de la Chapelle A: Genetic testing for cancer predisposition. Annu Rev Med. 52:371–400. 2001. View Article : Google Scholar : PubMed/NCBI | |
Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W and Press N: Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 296:1507–1517. 2006. View Article : Google Scholar : PubMed/NCBI | |
Peltomäki P: Lynch syndrome genes. Fam Cancer. 4:227–232. 2005. View Article : Google Scholar : PubMed/NCBI | |
Vasen HF: Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer. 4:219–225. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hampel H and Peltomaki P: Hereditary colorectal cancer: risk assessment and management. Clin Genet. 58:89–97. 2000. View Article : Google Scholar : PubMed/NCBI | |
Lynch HT and Smyrk T: Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer. 78:1149–1167. 1996. View Article : Google Scholar : PubMed/NCBI | |
Lynch HT, Smyrk T and Lynch JF: Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation. Oncology. 55:103–108. 1998. View Article : Google Scholar : PubMed/NCBI | |
Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL, et al: ASCO; SSO: ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol. 24:4642–4660. 2006. View Article : Google Scholar : PubMed/NCBI | |
Lynch HT and Lynch JF: What the physician needs to know about Lynch syndrome: an update. Oncology (Williston Park). 19:455–463; discussion 463–454, 466, 469. 2005.PubMed/NCBI | |
Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, et al: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 349:247–257. 2003. View Article : Google Scholar : PubMed/NCBI | |
Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58:5248–5257. 1998.PubMed/NCBI | |
Cunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y, Burgart LJ, Halling KC, McDonnell SK, Schaid DJ, Vockley C Walsh, et al: The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet. 69:780–790. 2001. View Article : Google Scholar : PubMed/NCBI | |
Rustgi AK: The genetics of hereditary colon cancer. Genes Dev. 21:2525–2538. 2007. View Article : Google Scholar : PubMed/NCBI | |
Peltomäki P and Vasen H: Mutations associated with HNPCC predisposition - Update of ICG-HNPCC/INSiGHT mutation database. Dis Markers. 20:269–276. 2004. View Article : Google Scholar : PubMed/NCBI | |
Plaschke J, Engel C, Krüger S, Holinski-Feder E, Pagenstecher C, Mangold E, Moeslein G, Schulmann K, Gebert J, von Knebel Doeberitz M, et al: Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol. 22:4486–4494. 2004. View Article : Google Scholar : PubMed/NCBI | |
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, et al: The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology. 135:419–428. 2008. View Article : Google Scholar : PubMed/NCBI | |
Bülow S: Familial polyposis coli. Dan Med Bull. 34:1–15. 1987. | |
Giardiello FM, Brensinger JD and Petersen GM: AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology. 121:198–213. 2001. View Article : Google Scholar : PubMed/NCBI | |
Soravia C, Berk T, McLeod RS and Cohen Z: Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum. 43:363–369. 2000. View Article : Google Scholar : PubMed/NCBI | |
Belchetz LA, Berk T, Bapat BV, Cohen Z and Gallinger S: Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum. 39:384–387. 1996. View Article : Google Scholar : PubMed/NCBI | |
Cetta F, Montalto G, Gori M, Curia MC, Cama A and Olschwang S: Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab. 85:286–92. 2000. View Article : Google Scholar : PubMed/NCBI | |
Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell. 61:759–767. 1990. View Article : Google Scholar : PubMed/NCBI | |
Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell. 87:159–170. 1996. View Article : Google Scholar : PubMed/NCBI | |
Bisgaard ML, Fenger K, Bülow S, Niebuhr E and Mohr J: Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat. 3:121–125. 1994. View Article : Google Scholar : PubMed/NCBI | |
Hes FJ, Nielsen M, Bik EC, Konvalinka D, Wijnen JT, Bakker E, Vasen HF, Breuning MH and Tops CM: Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut. 57:71–76. 2008. View Article : Google Scholar : PubMed/NCBI | |
Nieuwenhuis MH and Vasen HF: Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol. 61:153–161. 2007. View Article : Google Scholar : PubMed/NCBI | |
Galiatsatos P and Foulkes WD: Familial adenomatous polyposis. Am J Gastroenterol. 101:385–398. 2006. View Article : Google Scholar : PubMed/NCBI | |
Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, et al: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet. 17:79–83. 1997. View Article : Google Scholar : PubMed/NCBI | |
Gryfe R, Di Nicola N, Lal G, Gallinger S and Redston M: Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet. 64:378–384. 1999. View Article : Google Scholar : PubMed/NCBI | |
Claes K, Dahan K, Tejpar S, De Paepe A, Bonduelle M, Abramowicz M, Verellen C, Franchimont D, Van Cutsem E and Kartheuser A: The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP). Acta Gastroenterol Belg. 74:421–426. 2011.PubMed/NCBI | |
Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR, et al: Inherited variants of MYH associated with somatic G:C->T:A mutations in colorectal tumors. Nat Genet. 30:227–232. 2002. View Article : Google Scholar : PubMed/NCBI | |
Lefevre JH, Parc Y, Svrcek M, Kernéis S, Colas C, Shields C, Flejou JF, Parc R and Tiret E: APC, MYH, and the correlation genotype-phenotype in colorectal polyposis. Ann Surg Oncol. 16:871–877. 2009. View Article : Google Scholar : PubMed/NCBI | |
Morak M, Laner A, Bacher U, Keiling C and Holinski-Feder E: MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations. Clin Genet. 78:353–363. 2010. View Article : Google Scholar : PubMed/NCBI | |
Out AA, Tops CM, Nielsen M, Weiss MM, van Minderhout IJ, Fokkema IF, Buisine MP, Claes K, Colas C, Fodde R, et al: Leiden open variation database of the MUTYH gene. Hum Mutat. 31:1205–1215. 2010. View Article : Google Scholar : PubMed/NCBI | |
Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, Haile R, Hopper JL, LeMarchand L, Lindor N, et al: Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 136:1251–1260. 2009. View Article : Google Scholar : PubMed/NCBI | |
Nielsen M, Joerink-van de Beld MC, Jones N, Vogt S, Tops CM, Vasen HF, Sampson JR, Aretz S and Hes FJ: Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology. 136:471–476. 2009. View Article : Google Scholar : PubMed/NCBI | |
Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RK, Bisgaard ML, Orntoft TF, Aaltonen LA, Hodgson SV, et al: Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med. 348:791–799. 2003. View Article : Google Scholar : PubMed/NCBI | |
Lipton L and Tomlinson I: The multiple colorectal adenoma phenotype and MYH, a base excision repair gene. Clin Gastroenterol Hepatol. 2:633–638. 2004. View Article : Google Scholar : PubMed/NCBI | |
Halford SE, Rowan AJ, Lipton L, Sieber OM, Pack K, Thomas HJ, Hodgson SV, Bodmer WF and Tomlinson IP: Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol. 162:1545–1548. 2003. View Article : Google Scholar : PubMed/NCBI | |
Nielsen M, Morreau H, Vasen HF and Hes FJ: MUTYH-associated polyposis (MAP). Crit Rev Oncol Hematol. 79:1–16. 2011. View Article : Google Scholar : PubMed/NCBI | |
Jones S, Emmerson P, Maynard J, Best JM, Jordan S, Williams GT, Sampson JR and Cheadle JP: Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C->T:A mutations. Hum Mol Genet. 11:2961–2967. 2002. View Article : Google Scholar : PubMed/NCBI | |
Sampson JR, Dolwani S, Jones S, Eccles D, Ellis A, Evans DG, Frayling I, Jordan S, Maher ER, Mak T, et al: Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet. 362:39–41. 2003. View Article : Google Scholar : PubMed/NCBI | |
Enholm S, Hienonen T, Suomalainen A, Lipton L, Tomlinson I, Kärjä V, Eskelinen M, Mecklin JP, Karhu A, Järvinen HJ, et al: Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol. 163:827–832. 2003. View Article : Google Scholar : PubMed/NCBI | |
Wang L, Baudhuin LM, Boardman LA, Steenblock KJ, Petersen GM, Halling KC, French AJ, Johnson RA, Burgart LJ, Rabe K, et al: MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology. 127:9–16. 2004. View Article : Google Scholar : PubMed/NCBI | |
Jo WS, Bandipalliam P, Shannon KM, Niendorf KB, Chan-Smutko G, Hur C, Syngal S and Chung DC: Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol. 3:1022–1028. 2005. View Article : Google Scholar : PubMed/NCBI | |
Venesio T, Molatore S, Cattaneo F, Arrigoni A, Risio M and Ranzani GN: High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology. 126:1681–1685. 2004. View Article : Google Scholar : PubMed/NCBI | |
Knopperts AP, Nielsen M, Niessen RC, Tops CM, Jorritsma B, Varkevisser J, Wijnen J, Siezen CL, Heine-Bröring RC, van Kranen HJ, et al: Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review. Fam Cancer. 12:43–50. 2013. View Article : Google Scholar : PubMed/NCBI | |
Filipe B, Baltazar C, Albuquerque C, Fragoso S, Lage P, Vitoriano I, Mão de Ferro S, Claro I, Rodrigues P, Fidalgo P, et al: APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas. Clin Genet. 76:242–255. 2009. View Article : Google Scholar : PubMed/NCBI | |
Palles C, Cazier JB, Howarth KM, Domingo E, Jones AM, Broderick P, Kemp Z, Spain SL, Guarino E, Salguero I, et al: WGS500 Consortium: Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet. 45:136–144. 2013. View Article : Google Scholar : PubMed/NCBI | |
Valle L, Hernández-Illán E, Bellido F, Aiza G, Castillejo A, Castillejo MI, Navarro M, Seguí N, Vargas G, Guarinos C, et al: New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. Hum Mol Genet. 23:3506–3512. 2014. View Article : Google Scholar : PubMed/NCBI | |
Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Müller O, Back W and Zimmer M: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 18:38–43. 1998. View Article : Google Scholar : PubMed/NCBI | |
Donehower LA, Creighton CJ, Schultz N, Shinbrot E, Chang K, Gunaratne PH, Muzny D, Sander C, Hamilton SR, Gibbs RA, et al: MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. J Pathol. 229:99–110. 2013. View Article : Google Scholar : PubMed/NCBI | |
Church DN, Briggs SE, Palles C, Domingo E, Kearsey SJ, Grimes JM, Gorman M, Martin L, Howarth KM, Hodgson SV, et al: NSECG Collaborators: DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. Hum Mol Genet. 22:2820–2828. 2013. View Article : Google Scholar : PubMed/NCBI | |
Briggs S and Tomlinson I: Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers. J Pathol. 230:148–153. 2013. View Article : Google Scholar : PubMed/NCBI | |
Schreibman IR, Baker M, Amos C and McGarrity TJ: The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol. 100:476–490. 2005. View Article : Google Scholar : PubMed/NCBI | |
McGarrity TJ and Amos C: Peutz-Jeghers syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci. 63:2135–2144. 2006. View Article : Google Scholar : PubMed/NCBI | |
Gammon A, Jasperson K, Kohlmann W and Burt RW: Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol. 23:219–231. 2009. View Article : Google Scholar : PubMed/NCBI | |
Chow E and Macrae F: A review of juvenile polyposis syndrome. J Gastroenterol Hepatol. 20:1634–1640. 2005. View Article : Google Scholar : PubMed/NCBI | |
Boardman LA: Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am. 31:1107–1131. 2002. View Article : Google Scholar : PubMed/NCBI | |
Latchford AR, Neale K, Phillips RK and Clark SK: Juvenile polyposis syndrome: a study of genotype, phenotype, and long-term outcome. Dis Colon Rectum. 55:1038–1043. 2012. View Article : Google Scholar : PubMed/NCBI | |
Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, Velculescu VE, Traverso G and Vogelstein B: Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet. 28:184–187. 2001. View Article : Google Scholar : PubMed/NCBI | |
Howe JR, Ringold JC, Summers RW, Mitros FA, Nishimura DY and Stone EM: A gene for familial juvenile polyposis maps to chromosome 18q21.1. Am J Hum Genet. 62:1129–1136. 1998. View Article : Google Scholar : PubMed/NCBI | |
Howe JR, Roth S, Ringold JC, Summers RW, Järvinen HJ, Sistonen P, Tomlinson IP, Houlston RS, Bevan S, Mitros FA, et al: Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 280:1086–1088. 1998. View Article : Google Scholar : PubMed/NCBI | |
Zhou XP, Woodford-Richens K, Lehtonen R, Kurose K, Aldred M, Hampel H, Launonen V, Virta S, Pilarski R, Salovaara R, et al: Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet. 69:704–711. 2001. View Article : Google Scholar : PubMed/NCBI | |
Aretz S, Stienen D, Uhlhaas S, Stolte M, Entius MM, Loff S, Back W, Kaufmann A, Keller KM, Blaas SH, et al: High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet. 44:702–709. 2007. View Article : Google Scholar : PubMed/NCBI | |
Sayed MG, Ahmed AF, Ringold JR, Anderson ME, Bair JL, Mitros FA, Lynch HT, Tinley ST, Petersen GM, Giardiello FM, et al: Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol. 9:901–906. 2002. View Article : Google Scholar : PubMed/NCBI | |
Howe JR, Sayed MG, Ahmed AF, Ringold J, Larsen-Haidle J, Merg A, Mitros FA, Vaccaro CA, Petersen GM, Giardiello FM, et al: The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet. 41:484–491. 2004. View Article : Google Scholar : PubMed/NCBI | |
Friedl W, Uhlhaas S, Schulmann K, Stolte M, Loff S, Back W, Mangold E, Stern M, Knaebel HP, Sutter C, et al: Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet. 111:108–111. 2002. View Article : Google Scholar : PubMed/NCBI | |
Handra-Luca A, Condroyer C, de Moncuit C, Tepper M, Fléjou JF, Thomas G and Olschwang S: Vessels' morphology in SMAD4 and BMPR1A-related juvenile polyposis. Am J Med Genet A 138A. 113–117. 2005. View Article : Google Scholar | |
O'Malley M, LaGuardia L, Kalady MF, Parambil J, Heald B, Eng C, Church J and Burke CA: The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome. Dis Colon Rectum. 55:886–892. 2012. View Article : Google Scholar : PubMed/NCBI | |
Sweet K, Willis J, Zhou XP, Gallione C, Sawada T, Alhopuro P, Khoo SK, Patocs A, Martin C, Bridgeman S, et al: Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA. 294:2465–2473. 2005. View Article : Google Scholar : PubMed/NCBI | |
van Hattem WA, Brosens LA, de Leng WW, Morsink FH, Lens S, Carvalho R, Giardiello FM and Offerhaus GJ: Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut. 57:623–627. 2008. View Article : Google Scholar : PubMed/NCBI | |
Eng C and Ji H: Molecular classification of the inherited hamartoma polyposis syndromes: clearing the muddied waters. Am J Hum Genet. 62:1020–1022. 1998. View Article : Google Scholar : PubMed/NCBI | |
Dahdaleh FS, Carr JC, Calva D and Howe JR: Juvenile polyposis and other intestinal polyposis syndromes with microdeletions of chromosome 10q22-23. Clin Genet. 81:110–116. 2012. View Article : Google Scholar : PubMed/NCBI | |
Starink TM, van der Veen JP, Arwert F, de Waal LP, de Lange GG, Gille JJ and Eriksson AW: The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet. 29:222–233. 1986. View Article : Google Scholar : PubMed/NCBI | |
Heald B, Mester J, Rybicki L, Orloff MS, Burke CA and Eng C: Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology. 139:1927–1933. 2010. View Article : Google Scholar : PubMed/NCBI | |
Stanich PP, Owens VL, Sweetser S, Khambatta S, Smyrk TC, Richardson RL, Goetz MP and Patnaik MM: Colonic polyposis and neoplasia in Cowden syndrome. Mayo Clin Proc. 86:489–492. 2011. View Article : Google Scholar : PubMed/NCBI | |
Trufant JW, Greene L, Cook DL, McKinnon W, Greenblatt M and Bosenberg MW: Colonic ganglioneuromatous polyposis and metastatic adenocarcinoma in the setting of Cowden syndrome: a case report and literature review. Hum Pathol. 43:601–604. 2012. View Article : Google Scholar : PubMed/NCBI | |
Levi Z, Baris HN, Kedar I, Niv Y, Geller A, Gal E, Gingold R, Morgenstern S, Baruch Y, Leach BH, et al: Upper and lower gastrointestinal findings in pten mutation-positive cowden syndrome patients participating in an active surveillance program. Clin Transl Gastroenterol. 2:e52011. View Article : Google Scholar : PubMed/NCBI | |
Pilarski R: Cowden syndrome: a critical review of the clinical literature. J Genet Couns. 18:13–27. 2009. View Article : Google Scholar : PubMed/NCBI | |
McGarrity TJ, Baker MJ Wagner, Ruggiero FM, Thiboutot DM, Hampel H, Zhou XP and Eng C: GI polyposis and glycogenic acanthosis of the esophagus associated with PTEN mutation positive Cowden syndrome in the absence of cutaneous manifestations. Am J Gastroenterol. 98:1429–1434. 2003. View Article : Google Scholar : PubMed/NCBI | |
Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, et al: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 16:64–67. 1997. View Article : Google Scholar : PubMed/NCBI | |
Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, et al: Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet. 13:114–116. 1996. View Article : Google Scholar : PubMed/NCBI | |
Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG, et al: Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet. 6:1383–1387. 1997. View Article : Google Scholar : PubMed/NCBI | |
Lynch ED, Ostermeyer EA, Lee MK, Arena JF, Ji H, Dann J, Swisshelm K, Suchard D, MacLeod PM, Kvinnsland S, et al: Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet. 61:1254–1260. 1997. View Article : Google Scholar : PubMed/NCBI | |
Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:29–39. 1998. View Article : Google Scholar : PubMed/NCBI | |
Kalady MF, Jarrar A, Leach B, LaGuardia L, O'Malley M, Eng C and Church JM: Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum. 54:164–170. 2011. View Article : Google Scholar : PubMed/NCBI | |
Carvajal-Carmona LG, Howarth KM, Lockett M, Polanco-Echeverry GM, Volikos E, Gorman M, Barclay E, Martin L, Jones AM, Saunders B, et al: Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol. 212:378–385. 2007. View Article : Google Scholar : PubMed/NCBI | |
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ, et al: Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One. 5:e116362010. View Article : Google Scholar : PubMed/NCBI | |
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, Gattas M, Walsh MD, Clendenning M, McKeone D, Walters R, et al: Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis. 25:703–712. 2010. View Article : Google Scholar : PubMed/NCBI | |
Chow E, Lipton L, Lynch E, D'Souza R, Aragona C, Hodgkin L, Brown G, Winship I, Barker M, Buchanan D, et al: Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology. 131:30–39. 2006. View Article : Google Scholar : PubMed/NCBI | |
Young J and Jass JR: The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev. 15:1778–1784. 2006. View Article : Google Scholar : PubMed/NCBI | |
Boparai KS, Dekker E, Van Eeden S, Polak MM, Bartelsman JF, Mathus-Vliegen EM, Keller JJ and van Noesel CJ: Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology. 135:2014–2018. 2008. View Article : Google Scholar : PubMed/NCBI | |
Mongin C, Coulet F, Lefevre JH, Colas C, Svrcek M, Eyries M, Lahely Y, Fléjou JF, Soubrier F and Parc Y: Unexplained polyposis: a challenge for geneticists, pathologists and gastroenterologists. Clin Genet. 81:38–46. 2012. View Article : Google Scholar : PubMed/NCBI | |
Clendenning M, Young JP, Walsh MD, Woodall S, Arnold J, Jenkins M, Win AK, Hopper JL, Sweet K, Gallinger S, et al: Germline mutations in the polyposis-associated genes, and are not common in individuals with serrated polyposis syndrome. PLoS One. 8:e667052013. View Article : Google Scholar : PubMed/NCBI | |
Rebours V, Boutron-Ruault MC, Schnee M, Férec C, Maire F, Hammel P, Ruszniewski P and Lévy P: Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol. 103:111–119. 2008. View Article : Google Scholar : PubMed/NCBI | |
Greer JB, Whitcomb DC and Brand RE: Genetic predisposition to pancreatic cancer: a brief review. Am J Gastroenterol. 102:2564–2569. 2007. View Article : Google Scholar : PubMed/NCBI | |
Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, et al: Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56:5360–5364. 1996.PubMed/NCBI | |
Chapman PB: Melanoma vaccines. Semin Oncol. 34:516–523. 2007. View Article : Google Scholar : PubMed/NCBI | |
Pogue-Geile KL, Chen R, Bronner MP, Crnogorac-Jurcevic T, Moyes KW, Dowen S, Otey CA, Crispin DA, George RD, Whitcomb DC, et al: Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med. 3:e5162006. View Article : Google Scholar : PubMed/NCBI | |
Roberts NJ, Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy ML, Gallinger S, Schwartz AG, Syngal S, Cote ML, et al: ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov. 2:41–46. 2012. View Article : Google Scholar : PubMed/NCBI | |
Harinck F, Kluijt I, van Mil SE, Waisfisz Q, van Os TA, Aalfs CM, Wagner A, Olderode-Berends M, Sijmons RH, Kuipers EJ, et al: Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated. Eur J Hum Genet. 20:577–579. 2012. View Article : Google Scholar : PubMed/NCBI | |
Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, et al: Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science. 324:2172009. View Article : Google Scholar : PubMed/NCBI | |
Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG, Maung R, Seruca R, Jackson CE and Caldas C: Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med. 344:1904–1909. 2001. View Article : Google Scholar : PubMed/NCBI |